BRIEF-Pluristem Therapeutics up 7.2 percent premarket
January 21, 2014 at 07:37 AM EST
NEW YORK, Jan 21 (Reuters) - Pluristem Therapeutics Inc : * Up 7.2 percent to $4.75 in premarket after muscle injury treatment trial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.